Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-19-014428
Filing Date
2019-05-22
Accepted
2019-05-22 21:34:47
Documents
1
Period of Report
2019-05-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5672
  Complete submission text file 0000899243-19-014428.txt   7054
Mailing Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021
Business Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021 4255274000
SEATTLE GENETICS INC /WA (Issuer) CIK: 0001060736 (see all company filings)

EIN.: 911874389 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O RELYPSA, INC. 700 SAGINAW DR. REDWOOD CITY CA 94063
Business Address
Orwin John A (Reporting) CIK: 0001477384 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-32405 | Film No.: 19847755